Skip to main content
. 2020 Dec 2;27(1):1686–1694. doi: 10.1080/10717544.2020.1833381

Figure 1.

Figure 1.

Uses of optical/CT along the preclinical translational spectrum. 3D OI/ CT imaging allows for precise localization of the intracranial implanted NIR-labeled GBM cells. After GBM cell implantation, 3D OI/CT imaging enables visualization of the tumor growth and intracranial location of the tumor. 3D OI/CT imaging using Cy7 labeled albumin validates BBB opening with HIFU or CED drug delivery allowing visualization of drug distribution.